Europe Is Facing a Pancreatic Cancer Emergency
Me: What about everywhere else?
Europe Is Facing a Pancreatic Cancer Emergency
Siobhan Harris DISCLOSURES | January 25, 2024
Me: What about everywhere else?
"It's a health emergency for society, with mortality rates at over 90%," warned Professor Alfredo Carrato, the chairperson of Pancreatic Cancer Europe, speaking to Medscape Medical News.
Professor Alfredo Carrato, Pancreatic Cancer Europe
Pancreatic cancer is the seventh most common type of cancer in Europe but is the fourth leading cause of cancer-related deaths, behind lung, colorectal, and breast cancers. By 2030, it is widely predicted to become the second most common cause of cancer mortality.
There are many challenges with pancreatic cancer: Lack of awareness, difficult to diagnose, no screening programs for the general population, poor survival rate, and limited treatment options.
Life expectancy at the time of diagnosis is just 4.6 months. Only 3% of people diagnosed with pancreatic cancer will survive for 5 years.
A 2024 systematic analysis in The Lancet suggested that people living in Western Europe are more likely to develop pancreatic cancer than those living anywhere else in the world.
Medscape Medical News
Me: Of course, Pfizer and Moderna's ModRNA vaccines have nothing to do with it.
They’ve known for over 40 years that the LNPs wouldn’t stay in your arm. In fact, they didn’t ever want them to. They wanted the ‘vaccine’ to travel all round your body so that some of it would find its way to your lymph nodes. There, the dendritic cells were more likely to translate the mRNA as intended.
But they kept this quiet from you because would you really go and get injected if you were told that this new technology would travel all round your body where it would be taken up by all types of cells, including spleen, liver and ovary cells, which would then be instructed to produce a spike protein created in a lab somewhere, causing who knows what side effects because the trials were cancelled early
Dr. Cullis
Not mRNA but ModRNA made in a laboratory = patented to the vaccine maker of choice like just another GMO Product.
Perhaps the question to ask is how many "volunteers" diagnosed with pancreatic cancer, have been ModRNA vaccinated?